Cilnidipine
Especificaciones
118934-76-2Número CAS
634-350-6Número CE
3-O-(2-methoxyethyl) 5-O-[(E)-3-phenylprop-2-enyl] 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylateNombre IUPAC
C27H28N2O7Fórmula química
492.5 g/molPeso molecular
cilnidipine; 132203-70-4; Atelec; Cinalong; Siscard; FRC-8653; DTXSID0046309; cilnidipino; 97T5AZ1JIP; CHEBI:31399; 2-methoxyethyl (2E)-3-phenylprop-2-en-1-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; DTXCID8026309; O3-(2-methoxyethyl) O5-(3-phenylprop-2-enyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; cilnidipinum; RefChem:5688; 2-methoxyethyl-3-phenyl-2-propen-1-yl-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate; C08CA14; 3-(2-Methoxyethyl) 5-((2E)-3-phenylprop-2-en-1-yl) (4RS)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; 3-cinnamyl 5-(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; FRC 8653; Cilnidipine [INN]; Cilnidipine, (+)-; Cilnidipine, (-)-; MFCD00865853; (+-)-(E)-Cinnamyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3-(2-methoxyethyl) 5-[(2E)-3-phenyl-2-propen-1-yl] ester; 4LNU2SU262; 3-O-(2-methoxyethyl) 5-O-[(E)-3-phenylprop-2-enyl] 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; S85436ZG85; NCGC00162150-01; Cinaldipine; (+)-FRC-8653; (-)-FRC-8653; 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-methoxyethyl (2E)-3-phenyl-2-propenyl ester; 132295-21-7; 132338-87-5; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-methoxyethyl 3-phenyl-2-propenyl ester, (E)-(+)-; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-methoxyethyl 3-phenyl-2-propenyl ester, (E)-(-)-; Atelec (TN); CAS-132203-70-4; SR-05000001454; UNII-97T5AZ1JIP; Cilnidipine?; 3,5-PYRIDINEDICARBOXYLIC ACID, 1,4-DIHYDRO-2,6-DIMETHYL-4-(3-NITROPHENYL)-, 3-(2-METHOXYETHYL) 5-((2E)-3-PHENYL-2-PROPEN-1-YL) ESTER; Cilnidipine (Standard); CILNIDIPINE [MI]; CILNIDIPINE [JAN]; Cilnidipine (JP18/INN); CILNIDIPINE [MART.]; UNII-4LNU2SU262; SCHEMBL25550; CILNIDIPINE [WHO-DD]; CHEMBL452076; GTPL7767; orb1226543; orb1310660; Cilnidipine - Bio-X trade mark; SCHEMBL29367885; UNII-S85436ZG85; CHEBI:91506; BDBM642520; GLXC-07854; HMS2089J07; HMS3261E06; HMS3413L13; HMS3677L13; HMS3715N17; HMS3884K09; HMS5079L07; MSK11261; Tox21_112001; Tox21_500422; AC-270; BDBM50101813; HY-17404R; s1293; STK623341; AKOS005558085; Tox21_112001_1; CCG-221188; CCG-221726; Cilnidipine, >=98% (HPLC), powder; CS-1133; DB09232; FC20435; KS-1294; LP00422; SDCCGSBI-0633712.P001; US20230414632, Compound I-b; NCGC00162150-02; NCGC00162150-03; NCGC00162150-04; NCGC00162150-14; NCGC00162150-16; NCGC00261107-01; (E)-Cinnamyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-methoxyethyl 3-phenyl-2-propenyl ester, (E)-(+-)-; BC164309; HY-17404; LS-15175; O5-[(E)-cinnamyl] O3-(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; C2564; SW219784-1; D01173; SBI-0633712.0001; AB01274755-01; AB01274755-02; AB01274755_03; F800857; Q731525; SR-05000001454-1; SR-05000001454-2; BRD-A02743701-001-02-8; BRD-A02743701-001-03-6; BRD-A02743701-001-04-4; BRD-A07875874-001-01-6; F2173-0669; (+/-)-(E)-CINNAMYL 2-METHOXYETHYL 1,4-DIHYDRO-2,6-DIMETHYL-4-(M-NITROPHENYL)-3,5-PYRIDINEDICARBOXYLATE; 118934-76-2; 2-Methoxyethyl (2E)-3-Phenyl-2-propenyl 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate; 3-(2-Methoxyethyl) 5-[(2E)-3-phenylprop-2-en-1-yl] (4RS)- 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5- dicarboxylateSinónimos
